Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...

LoL's ARAM Mayhem mode is getting some significant updates in the 26.03 PBE, with new progession meta progress, new augments, and sets too.

Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with pharmaceutical and biotech heavyweights to rewire how drugs are discovered and ...

Hi! If you’re finding value in our Applied AI newsletter, I encourage you to consider subscribing to The Information. It ...

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...

Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Executives from Recursion (Nasdaq: RXRX), a leading clinical stage TechBio ...

Nathan Reiff has been writing expert articles and news about financial topics such as investing and trading, cryptocurrency, ETFs, and alternative investments on Investopedia since 2016. Robert Kelly ...

Andrew Bloomenthal has 20+ years of editorial experience as a financial journalist and as a financial services marketing writer. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced ...

A personal commercial (also known as an elevator speech, personal introduction, 30-second commercial, etc.) is a quick, effective way to make an impressive introduction. You will use your personal ...